Implantation of a Permanent Interatrial Shunt to Reduce Left Atrial Filling Pressures Following MitraClip
| 대상 질환 | Heart Failure, Mitral Regurgitation |
|---|---|
| 임상 단계 | 단계 해당 없음 |
| 스폰서 | samir kapadia |
| 상태 | 진행 중(모집 완료) |
| 참여자 수 | 16 명 |
| 중재(약물) | V-Wave Shunt Placement |
| 시작일 | 2021년 3월 11일 |
| 완료일 | 2025년 1월 3일 |
| 결과 공개일 | 2026년 8월 5일 |
요약
This is an investigator initiated, prospective study to demonstrate the safety and feasibility of implantation of the V-Wave Interatrial Shunt System (herein called the "V-Wave Shunt" in patients immediately following percutaneous mitral valve repair using the MitraClip system.
Number of Occurrence for Device-related Major Adverse Cardiovascular and Neurologic Events (MACNE)
| Treatment | 3 events |
|---|
BENITIONS에서 보기 ClinicalTrials.gov 원문 보기
같은 질환의 다른 임상
- Precision Guided Tacrolimus Dosing in Pediatric Heart Transplant — University of Utah
- Mechanism and Effects of Manipulating Chloride Homeostasis in Acute Heart Failure — Yale University
- Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using th — Boston Children's Hospital
- PROACTIVE-HF IDE Trial Heart Failure NYHA Class III — Endotronix, Inc.
- Improving How Older Adults at Risk for Cardiovascular Outcomes Are Selected for Care Coord — Weill Medical College of Cornell University
- Crome/Cobalt Respiration Study — Medtronic Cardiac Rhythm and Heart Failure